Price
Target price
€5.82
€5.82
8.610%
0.456
8.610%
€13.86
06.06.25 / Tradegate
WKN: A0LC2W / Symbol: EBS / Name: Emergent Bio / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Emergent Biosolutions Inc. Stock
Emergent Biosolutions Inc. dominated the market today, gaining €0.46 (8.610%).
With 13 Buy predictions and not the single Sell prediction the community is currently very high on Emergent Biosolutions Inc..
Based on the current price of 5.82 € the target price of 13 € shows a potential of 123.29% for Emergent Biosolutions Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Emergent Biosolutions Inc. stock. Criterium "Company culture" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Emergent Biosolutions Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Emergent Biosolutions Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc. | 8.610% | 2.284% | 38.356% | 1.358% | -25.282% | -80.167% | -92.488% |
| Ironwood Pharmaceuticals | -7.170% | -10.545% | -38.500% | -91.517% | -88.286% | -95.256% | -94.472% |
| Arrowhead Pharmaceuticals Inc. | 3.230% | 4.206% | 28.285% | -35.037% | -20.303% | -54.555% | -51.135% |
| Novocure Ltd | -1.370% | -14.583% | 0.174% | -29.371% | -50.618% | -80.703% | -76.153% |
Comments
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat
Emergent BioSolutions Inc. (NYSE: EBS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Show more
Ratings data for EBS provided by MarketBeat